These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 32733458)

  • 1. Norovirus Vaccine: Priorities for Future Research and Development.
    Esposito S; Principi N
    Front Immunol; 2020; 11():1383. PubMed ID: 32733458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial.
    Lindesmith LC; Ferris MT; Mullan CW; Ferreira J; Debbink K; Swanstrom J; Richardson C; Goodwin RR; Baehner F; Mendelman PM; Bargatze RF; Baric RS
    PLoS Med; 2015 Mar; 12(3):e1001807. PubMed ID: 25803642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus.
    Heinimäki S; Hankaniemi MM; Sioofy-Khojine AB; Laitinen OH; Hyöty H; Hytönen VP; Vesikari T; Blazevic V
    Vaccine; 2019 Dec; 37(51):7509-7518. PubMed ID: 31585726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress on norovirus vaccine research: public health considerations and future directions.
    Mattison CP; Cardemil CV; Hall AJ
    Expert Rev Vaccines; 2018 Sep; 17(9):773-784. PubMed ID: 30092671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera.
    Malm M; Tamminen K; Vesikari T; Blazevic V
    Viral Immunol; 2018 Dec; 31(10):649-657. PubMed ID: 30431404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous Immunization with Multivalent Norovirus VLPs Induces Better Protective Immune Responses to Norovirus Than Sequential Immunization.
    Malm M; Vesikari T; Blazevic V
    Viruses; 2019 Nov; 11(11):. PubMed ID: 31684058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype considerations for virus-like particle-based bivalent norovirus vaccine composition.
    Malm M; Tamminen K; Lappalainen S; Uusi-Kerttula H; Vesikari T; Blazevic V
    Clin Vaccine Immunol; 2015 Jun; 22(6):656-63. PubMed ID: 25903355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice.
    Tamminen K; Lappalainen S; Huhti L; Vesikari T; Blazevic V
    PLoS One; 2013; 8(7):e70409. PubMed ID: 23922988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal Antibodies Induced by Intranasal but Not Intramuscular Immunization Block Norovirus GII.4 Virus-Like Particle Receptor Binding.
    Tamminen K; Malm M; Vesikari T; Blazevic V
    Viral Immunol; 2016 Jun; 29(5):315-9. PubMed ID: 27135874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis.
    Richardson C; Bargatze RF; Goodwin R; Mendelman PM
    Expert Rev Vaccines; 2013 Feb; 12(2):155-67. PubMed ID: 23414407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quadrivalent norovirus vaccine based on a chimpanzee adenovirus vector induces potent immunity in mice.
    Jiang Y; Sun L; Qiao N; Wang X; Zhu C; Xing M; Liu H; Zhou P; Zhou D
    Virol Sin; 2024 Aug; 39(4):675-684. PubMed ID: 38997087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis.
    Blazevic V; Lappalainen S; Nurminen K; Huhti L; Vesikari T
    Vaccine; 2011 Oct; 29(45):8126-33. PubMed ID: 21854823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norovirus vaccines: Correlates of protection, challenges and limitations.
    Melhem NM
    Hum Vaccin Immunother; 2016 Jul; 12(7):1653-69. PubMed ID: 26836766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes.
    Malm M; Tamminen K; Heinimäki S; Vesikari T; Blazevic V
    Vaccine; 2018 Jan; 36(4):484-490. PubMed ID: 29246474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults.
    Bernstein DI; Atmar RL; Lyon GM; Treanor JJ; Chen WH; Jiang X; Vinjé J; Gregoricus N; Frenck RW; Moe CL; Al-Ibrahim MS; Barrett J; Ferreira J; Estes MK; Graham DY; Goodwin R; Borkowski A; Clemens R; Mendelman PM
    J Infect Dis; 2015 Mar; 211(6):870-8. PubMed ID: 25210140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control.
    Lopman BA; Steele D; Kirkwood CD; Parashar UD
    PLoS Med; 2016 Apr; 13(4):e1001999. PubMed ID: 27115709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-existing immunity to norovirus GII-4 virus-like particles does not impair de novo immune responses to norovirus GII-12 genotype.
    Tamminen K; Huhti L; Vesikari T; Blazevic V
    Viral Immunol; 2013 Apr; 26(2):167-70. PubMed ID: 23438469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of Recombinant Rotaviruses Expressing Human Norovirus Capsid Proteins.
    Philip AA; Patton JT
    J Virol; 2022 Nov; 96(22):e0126222. PubMed ID: 36314817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in human norovirus research and implications for candidate vaccines.
    Cates JE; Vinjé J; Parashar U; Hall AJ
    Expert Rev Vaccines; 2020 Jun; 19(6):539-548. PubMed ID: 32500763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine against norovirus.
    Tan M; Jiang X
    Hum Vaccin Immunother; 2014; 10(6):1449-56. PubMed ID: 24718366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.